Company Overview and News

0
Alkane Resources’ gold drilling results confirm near-mine potential at Tomingley

2018-07-11 proactiveinvestors.com.au
Alkane Resources Limited’s (ASX:ALK) recent drilling has intersected high-grade gold intercepts at the Roswell Prospect, part of its Tomingley Gold Operations (TGO) in New South Wales.
ALKEF ANLKY ALK

0
Alkane Resources says 'demand must come' for rare earths as EV revolution continues

2018-06-25 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK) managing director Nic Earner speaks to Proactive Investors about the junior exploration and mining company's multi-commodity portfolio of NSW projects; which includes the cash-generating Tomingley Gold Mine, the construction-ready Dubbo Project, and regional exploration.
ALKEF ANLKY ALK

0
Alkane Resources says 'demand must come' for zirconium as EV revolution continues

2018-06-25 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK) managing director Nic Earner speaks to Proactive Investors about the junior exploration and mining company's multi-commodity portfolio of NSW projects; which includes the cash-generating Tomingley Gold Mine, the construction-ready Dubbo Project, and regional exploration.
ALKEF ANLKY ALK

0
Alkane Resources director buys one million shares on-market

2018-06-07 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK) has received a vote of confidence from its technical director David Chalmers who has purchased one million shares in the company.
ALKEF ANLKY ALK

0
Alkane Resources confirms up to $1.2 billion valuation for Dubbo Project

2018-06-04 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK) has completed an engineering and financials review of its zirconium, niobium, hafnium and rare earths project, the Dubbo Project in New South Wales.
ALKEF ANLKY ALK

4
Alkane Resources is an award winning gold miner with a multi-commodity construction-ready project

2018-03-26 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK) has used its cash-generating Tomingley Gold Operation (TGO) in New South Wales to advance its Dubbo Project to a construction-ready stage.
ALKEF MALRY ANLKY ALK MALRF MIN

0
Alkane Resources wins mining operation of the year award

2018-03-20 proactiveinvestors.com.au
Alkane Resources Ltd (ASX:ALK) was recently awarded mining operation of the year as part of the New South Wales Minerals Council Suppliers Awards.
ALKEF ANLKY ALK

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:ALK / ALKANE RESOURCES LIMITED on message board site Silicon Investor.

Technology Stocks u0026 Market Talk With Don Wolanchuk Z Best Place to Talk Stocks
Bob Brinker, Moneytalk and Marketimer Walking for Health, Weight Loss or Pleasure
Diabetes, letu0027s talk about it Letu0027s Talk About the War
Bosco u0026 Crossyu0027s stock picks,talk area Talk City Inc - (Nasdaq-TCTY)
Letu0027s Talk About Our Feelings!!! Let���s Talk About Our Feelings about the Let���s Talk About Our